AbbVie : ABBV

All AbbVie Articles

612 Articles

Trey Thoelcke | Jun 23, 2026 at 7:55 AM EDT

3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal

Big pharma’s appetite for clinical-stage biotech is back. The pending acquisition of Apogee Therapeutics by AbbVie (NYSE: ABBV | ABBV…

Marc Guberti | Jun 21, 2026 at 4:17 PM EDT

The 2 Factors That Will Decide Whether XLV Finally Catches the S&P 500 in 2026

The Health Care Select Sector SPDR ETF (NYSEARCA:XLV) is having a frustrating year. The fund sits at $149, down about…

Drew Wood | Jun 19, 2026 at 2:56 PM EDT

The Retirement Portfolio That Forks Over a $10,000 Check Every Month

Ten thousand dollars a month works out to $120,000 a year, an income stream that exceeds the roughly $68,359 in…

Joel South | Jun 17, 2026 at 1:05 PM EDT

3 Dividend Stocks That Pay You More Every Single Year

Income investors keep coming back to the same playbook in choppy markets: own businesses that have raised their payouts every…

Drew Wood | Jun 17, 2026 at 8:59 AM EDT

How to Build $5,000 a Month in Dividend Income and Never Touch Your Principal

Five thousand dollars a month is the income many retirees are trying to generate from their investments. It is enough to…

Alex Sirois | Jun 16, 2026 at 4:42 PM EDT

This $15 Billion Operational Beat Just Rewrote the Entire Bear Thesis for AbbVie

For income investors weighing biopharma exposure, the dividend question on AbbVie (NYSE:ABBV | ABBV Price Prediction) just got a lot…

Vandita Jadeja | Jun 16, 2026 at 1:30 PM EDT

AbbVie Stock Will Hit $300 on This Date

AbbVie (NYSE:ABBV | ABBV Price Prediction) has quietly become one of healthcare’s most underrated growth stories. CEO Robert A. Michael…

Michael Williams | Jun 16, 2026 at 6:12 AM EDT

SCHD Now Concentrates 42 Percent of Your Money in Just 10 Stocks. Here Is Who Should Still Own It

Most Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) owners assume they are buying broad market diversification. The latest Schwab fact sheet…

Drew Wood | Jun 15, 2026 at 2:59 PM EDT

The Retiree Who Chose $65,000 Instead of $120,000 and Ended Up Richer

Two retirees walk into retirement with the same amount of money. One builds a portfolio that pays $120,000 a year…

John Seetoo | Jun 15, 2026 at 12:56 PM EDT

64 Years of Raises: How DGRO Finds Companies That Never Cut Dividends

The iShares Core Dividend Growth ETF (NYSEARCA:DGRO) was built for investors who want a paycheck that gets bigger every year,…

Joel South | Jun 13, 2026 at 9:30 AM EDT

3 Ridiculously Cheap Healthcare Stocks to Buy in June

Healthcare has spent 2026 on the sidelines while the rest of the market does the heavy lifting. The Health Care…

Drew Wood | Jun 13, 2026 at 8:02 AM EDT

Why a Dividend Portfolio That Pays Your Rent May Beat Homeownership by $500,000 Over 20 Years

Paying $2,000 a month in rent is often described as throwing money away. Homeownership, by contrast, is treated as the…

David Beren | Jun 12, 2026 at 7:23 AM EDT

Forget JEPI, Goldman’s S&P Income ETF Has Beaten It by 42 Points Since Launch

If you own JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI), you bought it for a reason that still holds. JEPI pays monthly. It…

Alex Sirois | Jun 11, 2026 at 2:22 PM EDT

Up 45% Since 2024: 1 Glaring Reality That Makes AbbVie Stock a Hold at $225

AbbVie (NYSE:ABBV | ABBV Price Prediction) at $224.95 sits at the center of a sharp bull-bear debate. The pharma giant…

Joel South | Jun 10, 2026 at 4:05 PM EDT

3 Dividend Stocks Built for Retirement to Buy in June

Mid-year is when income-focused investors tend to take a hard look at their portfolios. With the second half of 2026…

1 2 3 4 … 41

AbbVie : ABBV

All AbbVie Articles

3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal

The 2 Factors That Will Decide Whether XLV Finally Catches the S&P 500 in 2026

The Retirement Portfolio That Forks Over a $10,000 Check Every Month

3 Dividend Stocks That Pay You More Every Single Year

How to Build $5,000 a Month in Dividend Income and Never Touch Your Principal

This $15 Billion Operational Beat Just Rewrote the Entire Bear Thesis for AbbVie

AbbVie Stock Will Hit $300 on This Date

SCHD Now Concentrates 42 Percent of Your Money in Just 10 Stocks. Here Is Who Should Still Own It

The Retiree Who Chose $65,000 Instead of $120,000 and Ended Up Richer

64 Years of Raises: How DGRO Finds Companies That Never Cut Dividends

3 Ridiculously Cheap Healthcare Stocks to Buy in June

Why a Dividend Portfolio That Pays Your Rent May Beat Homeownership by $500,000 Over 20 Years

Forget JEPI, Goldman’s S&P Income ETF Has Beaten It by 42 Points Since Launch

Up 45% Since 2024: 1 Glaring Reality That Makes AbbVie Stock a Hold at $225

3 Dividend Stocks Built for Retirement to Buy in June

He Retired at 55 With $1.2 Million in His 401(k). One Routine Paperwork Move Would Have Locked It All Up for Years

Have a Big 401(k) and Turning 60? Your Catch-Up Limit Just Jumped to $11,250 and the Window Closes at 64

Chief Economic Adviser: “There Is No Way” the Bond Market Can Fund the AI Boom Without Higher Yields

He Retired at 55 With $1.2 Million in His 401(k). One Routine Paperwork Move Would Have Locked It All Up for Years

Have a Big 401(k) and Turning 60? Your Catch-Up Limit Just Jumped to $11,250 and the Window Closes at 64

He Retired at 55 With $1.2 Million in His 401(k). One Routine Paperwork Move Would Have Locked It All Up for Years

Have a Big 401(k) and Turning 60? Your Catch-Up Limit Just Jumped to $11,250 and the Window Closes at 64

AbbVie : ABBV

All AbbVie Articles

3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal

The 2 Factors That Will Decide Whether XLV Finally Catches the S&P 500 in 2026

The Retirement Portfolio That Forks Over a $10,000 Check Every Month

3 Dividend Stocks That Pay You More Every Single Year

How to Build $5,000 a Month in Dividend Income and Never Touch Your Principal

This $15 Billion Operational Beat Just Rewrote the Entire Bear Thesis for AbbVie

AbbVie Stock Will Hit $300 on This Date

SCHD Now Concentrates 42 Percent of Your Money in Just 10 Stocks. Here Is Who Should Still Own It

The Retiree Who Chose $65,000 Instead of $120,000 and Ended Up Richer

64 Years of Raises: How DGRO Finds Companies That Never Cut Dividends

3 Ridiculously Cheap Healthcare Stocks to Buy in June

Why a Dividend Portfolio That Pays Your Rent May Beat Homeownership by $500,000 Over 20 Years

Forget JEPI, Goldman’s S&P Income ETF Has Beaten It by 42 Points Since Launch

Up 45% Since 2024: 1 Glaring Reality That Makes AbbVie Stock a Hold at $225

3 Dividend Stocks Built for Retirement to Buy in June

He Retired at 55 With $1.2 Million in His 401(k). One Routine Paperwork Move Would Have Locked It All Up for Years

Have a Big 401(k) and Turning 60? Your Catch-Up Limit Just Jumped to $11,250 and the Window Closes at 64

Chief Economic Adviser: “There Is No Way” the Bond Market Can Fund the AI Boom Without Higher Yields

Featured Reads

He Retired at 55 With $1.2 Million in His 401(k). One Routine Paperwork Move Would Have Locked It All Up for Years

Have a Big 401(k) and Turning 60? Your Catch-Up Limit Just Jumped to $11,250 and the Window Closes at 64